Coconote
AI notes
AI voice & video notes
Try for free
🩸
Understanding GP2B3A Inhibitors in Medicine
Oct 18, 2024
GP2B3A Inhibitors: A Study Guide
Introduction to GP2B3A Inhibitors
Class of blood thinners.
Includes medications:
abciximab
,
tyrophaban
, and
eptafibetide
.
Mnemonic for GP2B3A
Grand Prix on lap 2 out of 3
helps remember GP2B3A.
GP
from Grand Prix.
2B3A
from lap 2 out of 3.
Mechanism of Action
GP2B3A (Glycoprotein 2B3A) is on platelet surface.
Inhibitors block this molecule to prevent platelet plug formation and blood clotting.
Drugs Overview
Abciximab
Mnemonic: ABC blocks.
Most common GP2B3A inhibitor.
Tyrophaban
Mnemonic: Tyrophaban Tyrannosaurus.
Eptafibetide
Mnemonic: Epitaph.
Clinical Uses
Anti-platelet drugs symbolized by "falling plates".
Prevent platelet clumping, crucial for:
Coronary artery stenting
.
Coronary emergencies
like unstable angina and myocardial infarctions.
Side Effects
Main side effect:
Bleeding
.
Symptoms include:
Hypotension and tachycardia.
Tarry stools or blood in urine.
Recommendation:
Avoid unnecessary invasive procedures.
Monitor hemoglobin and red blood cell levels closely.
Recap
GP2B3A inhibitors (abciximab, tyrophaban, eptifibatide) prevent platelet aggregation.
Useful in coronary procedures and emergencies.
Monitor for bleeding risks.
Conclusion
For more resources, subscribe to the channel and check out additional lessons and review materials.
📄
Full transcript